Evidence map›Paper›PMID 39628604›Full record

ReviewLeukemia research reports2024

An uncommon triad of myelodysplastic syndrome, Crohn's disease and autoimmune hepatitis: A case report and review of the literature.

Arij Cheffai, Wiem Boufrikha, Rim Rakez, Amina Ben Ghechir, Mohamed Adnène Laatiri

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Leukemia research reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arij CheffaiFattouma Bourguiba University Hospital of Monastir, Hematology Department, Monastir 5000, Tunisia.
Wiem BoufrikhaFattouma Bourguiba University Hospital of Monastir, Hematology Department, Monastir 5000, Tunisia.
Rim RakezFattouma Bourguiba University Hospital of Monastir, Hematology Department, Monastir 5000, Tunisia.
Amina Ben GhechirFattouma Bourguiba University Hospital of Monastir, Hematology Department, Monastir 5000, Tunisia.
Mohamed Adnène LaatiriFattouma Bourguiba University Hospital of Monastir, Hematology Department, Monastir 5000, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelodysplastic syndrome (MDS) is associated with an autoimmune disease (AD) in 10 to 20% of cases. Crohn's disease (CD) is not a common autoimmune manifestation reported with MDS. The triad made up of MDS, CD and another autoimmune manifestation is even more unusual. To our knowledge, only four cases with this triad have been reported in the literature to date, and ours is the fifth. It's about a 50-year-old man with a history of autoimmune hepatitis who was diagnosed, five years later, with MDS with multilineage dysplasia. He was started on Azacitidine three weeks before retaining the diagnosis of an associated CD.

Indexed as

AssociationAutoimmune diseasesCrohn's diseaseMyelodysplastic syndrome

Identifiers

PMID39628604
PMCPMC11612820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.